PT Diagnos Laboratorium Utama Tbk

Jakarta Stock Exchange DGNS.JK

PT Diagnos Laboratorium Utama Tbk Price to Earnings Ratio (P/E) on January 14, 2025: -17.43

PT Diagnos Laboratorium Utama Tbk Price to Earnings Ratio (P/E) is -17.43 on January 14, 2025, a 24.43% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • PT Diagnos Laboratorium Utama Tbk 52-week high Price to Earnings Ratio (P/E) is -17.03 on December 30, 2024, which is 2.35% above the current Price to Earnings Ratio (P/E).
  • PT Diagnos Laboratorium Utama Tbk 52-week low Price to Earnings Ratio (P/E) is -35.15 on March 15, 2024, which is -101.61% below the current Price to Earnings Ratio (P/E).
  • PT Diagnos Laboratorium Utama Tbk average Price to Earnings Ratio (P/E) for the last 52 weeks is -22.70.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
Jakarta Stock Exchange: DGNS.JK

PT Diagnos Laboratorium Utama Tbk

CEO Engineer Mesha Rizal Sini
IPO Date Jan. 15, 2021
Location Indonesia
Headquarters Gedung Graha Anam Lantai 2
Employees 91
Sector Health Care
Industries
Description

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; anatomical pathology laboratory tests for examination of tissues and/or body fluids; and genomics laboratory tests comprising non-invasive prenatal testing, preimplantation genetic testing for aneuploidy services, and preimplantation genetic testing for monogenic diseases services. It also offers homecare health services for health checks that can be done at home; corporate health services; and covid-19 check-up services, as well as health care activities managed by the government and the private sector, such as pharmacy warehouses, eye banks, blood banks, sperm banks, organ transplant banks, and other health care services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.

Similar companies

DMMX.JK

PT Digital Mediatama Maxima Tbk

USD 0.01

-1.29%

HEAL.JK

PT Medikaloka Hermina Tbk

USD 0.10

1.68%

BMHS.JK

PT Bundamedik Tbk

USD 0.01

-0.36%

IRRA.JK

PT Itama Ranoraya Tbk

USD 0.02

-1.00%

PRDA.JK

PT Prodia Widyahusada Tbk

USD 0.16

1.27%

StockViz Staff

January 15, 2025

Any question? Send us an email